1.
Where a Member State concerned has justified grounds for considering that the requirements set out in this Regulation are no longer met, it may take the following measures on its territory: revoke the authorisation of a clinical trial; suspend a clinical trial; require the sponsor to modify any aspect of the clinical trial.
← Article 77 · All articles · art_77__para_1__text_1 →
Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.